We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
-8.32%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.29B
AUM Growth
-$303M
Cap. Flow
+$76.4M
Cap. Flow %
2.32%
Top 10 Hldgs %
14.37%
Holding
1,576
New
105
Increased
568
Reduced
547
Closed
231

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$15.9M
2
KMX icon
CarMax
KMX
+$10.9M
3
NFLX icon
Netflix
NFLX
+$7.39M
4
UAL icon
United Airlines
UAL
+$6.3M
5
AMZN icon
Amazon
AMZN
+$5.34M

Top Sells

Rank Stock Value
1
COP icon
ConocoPhillips
COP
+$6.94M
2
QCOM icon
Qualcomm
QCOM
+$6.76M
3
BHC icon
Bausch Health
BHC
+$5.37M
4
KMI icon
Kinder Morgan
KMI
+$5.15M
5
PLL
PALL CORP
PLL
+$5.04M

Sector Composition

Rank Sector Weight
1 Healthcare 15.4%
2 Financials 10.61%
3 Consumer Discretionary 9.72%
4 Industrials 9.63%
5 Technology 9.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGFSW
1326
DELISTED
AgroFresh Solutions Inc Warrants
AGFSW
$22K ﹤0.01%
+10,000
New +$22.9K
APYX icon
1327
Apyx Medical
APYX
$173M
$21K ﹤0.01%
10,900
HNR
1328
DELISTED
Harvest Natural Resources
HNR
$20K ﹤0.01%
3,625
AXAS
1329
DELISTED
Abraxas Petroleum Corp
AXAS
$19K ﹤0.01%
750
ERNA icon
1330
Eterna Therapeutics
ERNA
$3.83M
0
PLX icon
1331
Protalix BioTherapeutics
PLX
$191M
$18K ﹤0.01%
1,500
PVLA
1332
Palvella Therapeutics
PVLA
$1.99B
$18K ﹤0.01%
+125
New +$27.9K
BTU
1333
DELISTED
PEABODY ENERGY CORP COM STK NEW (DE)
BTU
$17K ﹤0.01%
831
-2,620
-76% -$59.2K
SD
1334
DELISTED
SANDRIDGE ENERGY, INC.
SD
$16K ﹤0.01%
60,700
-1,000
-2% -$523
GIGM icon
1335
GigaMedia
GIGM
$15.7M
$15K ﹤0.01%
6,094
-5,275
-46% -$16.5K
MNI
1336
DELISTED
The McClatchy Company Class A Common Stock
MNI
$13K ﹤0.01%
1,370
CGRN
1337
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$11K ﹤0.01%
165
-4
-2% -$293
CNTF
1338
DELISTED
China TechFaith Wireless Communication Technology Ltd
CNTF
$11K ﹤0.01%
4,000
XRA
1339
DELISTED
Exeter Resources Corporation
XRA
$9K ﹤0.01%
27,042
-300
-1% -$119
KEG
1340
DELISTED
KEY ENERGY SERVICES INC
KEG
$9K ﹤0.01%
20,000
PWE
1341
DELISTED
Penn West Energy Petroleum Ltd
PWE
$7K ﹤0.01%
16,782
-800
-5% -$782
PLG
1342
Platinum Group Metals
PLG
$164M
$4K ﹤0.01%
190
IO
1343
DELISTED
ION Geophysical Corporation
IO
$4K ﹤0.01%
700
GCVRZ
1344
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$3K ﹤0.01%
18,979
-9,490
-33% -$3.23K
ACHV icon
1345
Achieve Life Sciences
ACHV
$659M
-7
Closed -$35K
AGIO icon
1346
Agios Pharmaceuticals
AGIO
$1.79B
-2,000
Closed -$222K
AIR icon
1347
AAR Corp
AIR
$5.59B
-15,927
Closed -$508K
ALK icon
1348
Alaska Air
ALK
$5.29B
-7,561
Closed -$487K
ALSN icon
1349
Allison Transmission
ALSN
$9.5B
-7,342
Closed -$215K
ANIP icon
1350
ANI Pharmaceuticals
ANIP
$1.8B
-4,630
Closed -$287K

Similar funds

Oppenheimer & Co's Q3 2015 Portfolio in Review

As of Q3 2015, Oppenheimer & Co held 1,576 positions worth $3.29B, down 8.4% from $3.59B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co's Q3 2015 filing shows 105 new, 568 increased, 547 reduced and 231 closed positions. Its largest new stake was PayPal: 112,571 shares worth $3.49M. The largest sale was ConocoPhillips, an estimated $6.94M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Oppenheimer & Co's largest Q3 2015 buy was PayPal: 112,571 shares worth $3.49M.
  • Oppenheimer & Co added most to Gilead Sciences in Q3 2015, an estimated $15.9M increase.
  • Oppenheimer & Co's biggest Q3 2015 reduction was ConocoPhillips, cutting an estimated $6.94M.
  • Oppenheimer & Co fully exited PALL CORP in Q3 2015, selling an estimated $5.04M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.29B portfolio in Q3 2015.
  • Oppenheimer & Co opened 105 new positions and closed 231 in Q3 2015.
  • Oppenheimer & Co's portfolio value fell 8.4% quarter-over-quarter to $3.29B.

Based on Oppenheimer & Co's 13F filing for Q3 2015, filed 13 Nov 2015.